NCT02677714View on ClinicalTrials.gov

99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 2, 2016

Primary Completion Date

October 12, 2018

Study Completion Date

October 12, 2018

Conditions
Breast CancerDoxorubicin Induced Cardiomyopathy
Interventions
RADIATION

99mTc-rhAnnexin V-128

Kit for the preparation of 99mTc-rhAnnexin V-128

Trial Locations (1)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

Sponsors
All Listed Sponsors
lead

Advanced Accelerator Applications

INDUSTRY